REFRACTORY MEDIASTINAL LYMPHOMA

Clinical trials for REFRACTORY MEDIASTINAL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY MEDIASTINAL LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY MEDIASTINAL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New combo therapy tested for aggressive lymphomas

Disease control Completed

This early-stage trial tested a new combination of two immune-based drugs, lenalidomide and blinatumomab, for adults with non-Hodgkin lymphoma that has come back or stopped responding to other treatments. The main goal was to find the safest dose and understand the side effects. …

Matched conditions: REFRACTORY MEDIASTINAL LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

REFRACTORY MEDIASTINAL LYMPHOMA

Get alerted when new REFRACTORY MEDIASTINAL LYMPHOMA trials appear

New combo therapy tested for aggressive lymphomas